The effect of orlistat on plasma levels of psychotropic drugs in patients with long-term psychopharmacotherapy

Journal of Clinical Psychopharmacology

Volumn 22, Issue 1, 2002, Pages 68-70

  Hilger, E ^a   Quiner, S ^a   Ginzel, I ^a   Walter, H ^a   Saria, L ^a   Barnas, C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOMIPRAMINE; CLOZAPINE; DESIPRAMINE; HALOPERIDOL; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DEPRESSION; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; OBESITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ANTI-OBESITY AGENTS; BIOLOGICAL AVAILABILITY; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LACTONES; LONG-TERM CARE; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; WEIGHT GAIN;

EID: 0036157184     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200202000-00011     Document Type: Article

References (10)

1. Weight gain and antipsychotic medication
2. Weight gain associated with use of psychotropic medications
3. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
4. Obesity: A time bomb to be defused
5. Mode of action of orlistat
6. The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers
7. The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of betacarotene in healthy volunteers
8. Effect of orlistat on blood cyclosporine concentrations in an obese heart transplant patient